these substances decrease superoxide generation in the three systems. The effects of these two agents seem to be the result of an intracellular mechanism resulting in the intervention of the oxidative metabolism of neutrophils since no effect was found in the cell-free systems. Therefore, this in vitro study suggests that at therapeutic concentrations, dirithromycin and erythromycylamine could benefit therapy by stimulation of the oxidative metabolism of neutrophils.
Polymorphonuclear neutrophils (PMN) play a prominent role in the host response to infectious diseases. An important bactericidal mechanism employed by these cells is the production of reactive compoundsof oxygen during the oxidative burst1}. These compounds are essential for destruction of a great variety of bacteria. The enzyme superintendent for this process is NADPHoxidase, which reduces the atmospheric oxygen in superoxide anion (O^~ Bacteria were inoculated at a final concentration of 9 x 107/ml.
Cellular Viability after the Reaction of Agents
To control the cellular viability after exposure to reagents the cytosolic enzyme lactate dehydrogenase (LDH), was determined after each cellular experience17). The neutrophils were incubated at 37°C in the presence of drugs or solvents and the liberation of LDHwas determined. Results were expressed in percentage of LDH activity. JAN. 1997 Effect of the Dirithromycin and the Erythromycylamine on the Superoxide Production Scavenging of Superoxide Anion (O^) Superoxide anion was generated by the hypoxanthine- 
Statistical Studies
The data obtained was subjected to statistical analysis using a non-parametric test (Wilcoxon) where P val- was not substantially modified after one hour of incubation in the presence of these agents: the LDH activity was maintained at less of 20%17). This significant increase can result only by a cellular mechanism by the intervention of oxidative neutrophil metabolism, since no significant effect was found in the cell-free system.
Effect of Dirithromycin and Erythromycylamine on Superoxide Production by
It is suggested that the probable mechanism of the increase of the O^production by the antibiotic comes from a stimulation of the phospholipase C. The former activates of DAGand therefore the NADPH-oxidase15).
This capacity to induce production of O2 by PMNhas been shown previously for other macrolides such as josamycin13 '20) , erythromycin and miocamycin21).
Our results are in disagreement with Hand22) and Joone23) concerning dirithromycin; which may be ex- '23) and other macroIides7?24 '25) , that inhibition could have resulted from an inhibition of PKC and an inhibition of the fMLP transductional pathway.
Pro-oxidant and anti-oxidant effects observed with dirithromycin are more pronounced than with erythromycylamine due to better intracellular penetration. Data (Eli Lilly on file) indicates that dirithromycin is more hydrophobic than erythromycylamine26), and therefore would cross the neutrophil membranemore rapidly.
These results are confirmed by other observations on PMNdegranulation: the necessary minimal concentration to generate PMNdegranulation seems to be lower with dirithromycin than with its hydrolysis derivative27). Dirithromycin concentrates in humanneutrophils in a time-dependent mannerwith a cellular concentration/extracellular concentration ratio (C/E) of 9 in the first 5 minutes and 47 at 120 minutes26 
